Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Functional Impact	Mutation Type	Variant Type	Copy #	COSMIC	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Administration Of Drug Weeks	Diagnosis Age	AGENT	Durable Clinical Benefit	Event Type	Fraction Genome Altered	Histology	Molecular Smoking Signature	Neoantigen Burden	Nonsynonymous Mutation Burden	Note	Oncotree Code	PDL1 Expression	Progress Free Survival (Months)	Prior Treatment Of Cytotoxic Chemotherapy	Number of Samples Per Patient	Sex	Smoking History	Person Cigarette Smoking History Pack Year Value	Somatic Status	TMB (nonsynonymous)	Total Exonic Mutation Burden	Treatment best response	Clinical Trial	Driver Mutations	Gene Panel	Immunotherapy	Institute Source	Number Treatment Lines Prior To Receiving Impact Results	Metastatic Site	Overall Patient Histology	Primary Tumor Site	Recurrent/metastatic disease	Sample Class	Sample coverage	Sample pre any Lung Therapy	Sample Type	SO comments	Stage At Diagnosis	Target Therapy	Chemotherapy	Tumor Purity	Patient's Vital Status	Patient Current Age	Dosage	Mean Target Coverage Normal	Mean Target Coverage Tumor	Overall Response	Progression Free Status	Sample Collection Source	Person Cigarette Smoking History Pack Year Value	Tissue Source Site	Treatment Schedule	Age (yrs)	Best Overall Response	ECOG performance status	HLA_A1 allele	HLA_A2 alleles	HLA_B1 alleles	HLA_B2 alleles	HLA_C1 alleles	HLA_C2 alleles	PD-L1 expression (Percentage)	Predicted neoantigen burden	Smoking Status	FGA	IRB	Lines of treatment	Mutation Rate	PD-L1 Score (%)	Smoker	Treatment Type
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0001836-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L158V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.07;Polyphen-2: impact: probably_damaging, score: 0.991	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	62007210	62007210	G	C	17:g.62007210G>C	ENST00000006750.3:c.469C>G	0.10		90	845		510	21	4/6						60		NO		0.3102						LUAD		1.77		1	Female			Matched	23.2922613126					IMPACT341																							1:Progressed																	0.31	Commercial	2	23.46938776		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0002969-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V212M	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	62006645	62006645	C	T	17:g.62006645C>T	ENST00000006750.3:c.631G>A	0.36		161	286		336	20	6/6						56		NO		0.1105						LUAD		0.73		1	Male			Matched	22.183106012					IMPACT341																							1:Progressed																	0.11	Commercial	4	20.40816327		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0006895-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q154K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.16;Polyphen-2: impact: benign, score: 0.003	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	62007222	62007222	G	T	17:g.62007222G>T	ENST00000006750.3:c.457C>A	0.13		132	884		487	37	4/6	0.00000398203		rs756467709			65		YES		0.0011						LUAD		9.37		1	Male			Matched	36.2126288117					IMPACT410																							0:Not Progressed																	0	Commercial	2	34.90566038		Ever	Monotherapy
Non-Small Cell Lung Cancer (MSKCC, J Clin Oncol 2018)	P-0016033-T01-IM6	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L158M	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: probably_damaging, score: 0.998	Missense_Mutation	SNP	Diploid		SOMATIC	Unknown	MSKCC	17	62007210	62007210	G	T	17:g.62007210G>T	ENST00000006750.3:c.469C>A	0.23		304	1010		598	34	4/6						72		NE		0.1663						LUAD		5.5		1	Male			Matched	28.5350371345					IMPACT468																							0:Not Progressed																	0.17	Commercial	1	27.04918033	90	Ever	Monotherapy
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0001836-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	L158V	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.07;Polyphen-2: impact: probably_damaging, score: 0.991	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	62007210	62007210	G	C	17:g.62007210G>C	ENST00000006750.3:c.469C>G							21	4/6						59				0.3102						LUAD				1	Female	Former heavy		Matched	23.2922613126			NO	UNKNOWN DRIVER	IMPACT341	YES	MSKCC	0	Lymph Node	Adenocarcinoma	Lung	YES	Tumor	748	YES	Metastasis		IV	NO	YES	30	AWD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0002969-T01-IM3	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	V212M	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: deleterious, score: 0.01;Polyphen-2: impact: probably_damaging, score: 0.999	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	62006645	62006645	C	T	17:g.62006645C>T	ENST00000006750.3:c.631G>A							20	6/6						53				0.1105						LUAD				1	Male	Former heavy		Matched	22.183106012			NO	UNKNOWN DRIVER	IMPACT341	YES	MSKCC	1	Pancreas	Adenocarcinoma	Lung	YES	Tumor	462	NO	Metastasis	Note: A comparison of variant frequencies suggests the RFWD2 (p.R273I), FH (p.G346C) and SPEN (p.A1061G) mutations are subclonal.	IIIA	NO	YES	20	DOD																													
Non-Small Cell Cancer (MSKCC, Cancer Discov 2017)	P-0006895-T01-IM5	Non-Small Cell Lung Cancer	Lung Adenocarcinoma	Q154K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;MyCancerGenome: not present;CancerHotspot: no;3DHotspot: no	SIFT: impact: tolerated, score: 0.16;Polyphen-2: impact: benign, score: 0.003	Missense_Mutation	SNP	Diploid		SOMATIC	NA	MSKCC	17	62007222	62007222	G	T	17:g.62007222G>T	ENST00000006750.3:c.457C>A							37	4/6	0.00000398203		rs756467709			64				0.0011						LUAD				1	Male	Former heavy		Matched	36.2126288117			YES	ERBB3_MUT	IMPACT410	NO	MSKCC	0	Adrenal	Adenocarcinoma	Lung	YES	Tumor	882	YES	Metastasis	Note: Low tumor content (approximately 20% or less). Negative mutation, copy number and structural variant results should be interpreted with caution.	IV	NO	YES		AWD																													
